Clinical inertia, the tendency to maintain current treatment strategies despite results demanding escalation, is thought to substantially contribute to the disconnect between clinical aspirations towards optimal control of the disease and reduction in complications for patients with diabetes and targets achieved. The Time2DoMore project is a collaboration between the International Diabetes Federation and experts from around the world, sponsored by Novartis. It’s aim is to ㆍidentify barriers in improving the treatment of type 2 diabetes and understand ways these can be overcome; ㆍunderstand clinical inertia and to what extent it constitutes a barrier to improving care in type 2 diabetes, ㆍexplore perceptions on treating earlier and more aggressively and ㆍidentify areas of unmet need. By conducting a 20-minute online survey of 652 adults with diabetes and 337 treating physicians in six countries, we have explored opinions relating to clinical inertia from both perspectives, in order to correlate perceptions and expectations relating to diagnosis, treatment, diabetic complications and therapeutic escalation. The findings are remarkably constant independent of the setting and countries, such as the observation that Physicians have low expectations for their patients, despite the belief that the importance of good glycaemic control through lifestyle and pharmacological interventions. Conversely, people with diabetes have, at best, a rudimentary understanding of the risks of complications and the importance of good control; indeed, only a small proportion believe lifestyle changes are important and the majority do not intend to comply. This presentation will present the principal findings of the survey. It suggests that impairments in communication are at the heart of clinical inertia. I will present some key strategies in order to try to combat clinical inertia in daily practice. The complete manuscript for physicians can be downloaded at http://www.diabetesresearchclinicalpractice.com/article/S0168-8227(14)00219-8/pdf additionally a secondary manuscript aimed at people with diabetes can be found at http://www.idf.org/sites/default/files/attachments/2014_3_Strain_EN.pdf.